Koninklijke Philips N.V. (RYLPF)
OTCMKTS · Delayed Price · Currency is USD
28.42
+0.72 (2.61%)
Sep 22, 2025, 9:12 AM EDT
Koninklijke Philips Market Cap
Koninklijke Philips has a market cap or net worth of $26.58 billion as of September 23, 2025. Its market cap has decreased by -7.29% in one year.
Market Cap
26.58B
Enterprise Value
34.41B
Revenue
20.97B
Ranking
n/a
PE Ratio
139.73
Stock Price
$28.42
Market Cap Chart
Since December 31, 1985, Koninklijke Philips's market cap has increased from 4.79B to 26.58B, an increase of 454.90%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 26.60B | 12.75% |
| Dec 31, 2024 | 23.60B | 13.34% |
| Dec 29, 2023 | 20.82B | 61.11% |
| Dec 30, 2022 | 12.92B | -58.63% |
| Dec 31, 2021 | 31.23B | -34.24% |
| Dec 31, 2020 | 47.50B | 11.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 705.53M |
| Elite Pharmaceuticals | 668.08M |
| Glass House Brands | 538.12M |
| Northwest Biotherapeutics | 376.78M |
| CytoDyn | 351.92M |
| American Oncology Network | 341.95M |
| Nika Pharmaceuticals | 299.34M |